Omega Healthcare Investors, Inc. (NYSE:OHI) Shares Bought by Rainey & Randall Wealth Advisors Inc.

Rainey & Randall Wealth Advisors Inc. lifted its stake in Omega Healthcare Investors, Inc. (NYSE:OHI) by 1.1% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 179,004 shares of the real estate investment trust’s stock after acquiring an additional 2,026 shares during the quarter. Omega Healthcare Investors comprises approximately 1.3% of Rainey & Randall Wealth Advisors Inc.’s portfolio, making the stock its 16th largest position. Rainey & Randall Wealth Advisors Inc.’s holdings in Omega Healthcare Investors were worth $6,775,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Daiwa Securities Group Inc. raised its position in shares of Omega Healthcare Investors by 317.7% in the 3rd quarter. Daiwa Securities Group Inc. now owns 3,949,368 shares of the real estate investment trust’s stock valued at $160,739,000 after purchasing an additional 3,003,845 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Omega Healthcare Investors by 328.6% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,661,964 shares of the real estate investment trust’s stock valued at $67,642,000 after acquiring an additional 1,274,238 shares during the period. FMR LLC boosted its position in Omega Healthcare Investors by 9.9% during the 3rd quarter. FMR LLC now owns 4,216,835 shares of the real estate investment trust’s stock valued at $171,625,000 after purchasing an additional 380,626 shares during the period. Franklin Resources Inc. grew its position in shares of Omega Healthcare Investors by 441.4% during the third quarter. Franklin Resources Inc. now owns 429,993 shares of the real estate investment trust’s stock worth $17,177,000 after acquiring an additional 350,570 shares during the last quarter. Finally, Parallax Volatility Advisers L.P. grew its position in Omega Healthcare Investors by 115.9% in the 3rd quarter. Parallax Volatility Advisers L.P. now owns 34,982 shares of the real estate investment trust’s stock worth $1,424,000 after purchasing an additional 254,471 shares during the last quarter. Institutional investors and hedge funds own 65.25% of the company’s stock.

Omega Healthcare Investors Price Performance

NYSE OHI opened at $35.68 on Friday. The company has a current ratio of 7.07, a quick ratio of 7.07 and a debt-to-equity ratio of 1.02. Omega Healthcare Investors, Inc. has a 1 year low of $29.66 and a 1 year high of $44.42. The company has a market cap of $10.05 billion, a PE ratio of 23.02, a PEG ratio of 1.09 and a beta of 0.99. The stock’s 50-day moving average price is $37.38 and its two-hundred day moving average price is $39.04.

Omega Healthcare Investors (NYSE:OHI) last released its quarterly earnings results on Wednesday, February 5th. The real estate investment trust reported $0.74 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.41 by $0.33. Omega Healthcare Investors had a net margin of 38.65% and a return on equity of 9.71%. On average, analysts predict that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current year.

Omega Healthcare Investors Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, February 18th. Stockholders of record on Monday, February 10th were issued a $0.67 dividend. The ex-dividend date of this dividend was Monday, February 10th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 7.51%. Omega Healthcare Investors’s payout ratio is currently 172.90%.

Wall Street Analyst Weigh In

OHI has been the topic of a number of research analyst reports. JMP Securities reissued a “market perform” rating on shares of Omega Healthcare Investors in a report on Friday, February 7th. BMO Capital Markets raised Omega Healthcare Investors from a “market perform” rating to an “outperform” rating and set a $45.00 target price on the stock in a report on Monday, December 9th. Mizuho upped their price target on shares of Omega Healthcare Investors from $35.00 to $37.00 and gave the company a “neutral” rating in a report on Thursday, December 5th. Royal Bank of Canada lifted their price objective on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a “sector perform” rating in a research note on Monday, November 11th. Finally, BNP Paribas upgraded shares of Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 target price on the stock in a report on Thursday, October 31st. Five investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $41.67.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.